Technology | March 29, 2011

FDA Clears Wireless Point-of-Care Blood Testing System

March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from the patient bedside.

The new i-Stat 1 wireless handheld, from Abbott, offers several types of test cartridges, including a cardiac troponin test. Blood is added to disposable cartridges that contain test reagents. The cartridge is then inserted in the analyzer and results are provided in minutes. In addition to cardiac markers, other tests include chemistries, blood gases, electrolytes and tests for lactate, hemoglobin, coagulation and hematology.

"With i-Stat 1 Wireless, caregivers are able to share critical test information electronically without leaving the patient's bedside," said Greg Arnsdorff, head of Abbott's point of care business. "By empowering nurses to stay at the bedside, the new i-Stat 1 Wireless supports a patient-focused approach to treatment, allowing for expedited decision making that helps minimize time to treatment."

The handheld analyzer can potentially save time by allowing caregivers to perform critical tests at the bedside and then transmit test results immediately. Physicians can then review the results from anywhere they have access to electronic records. Eliminating back-and-forth movement from the bedside to a desktop transmission terminal somewhere in the department gives staff the ability to better focus on the patient.

"With wireless, physicians can receive immediate test information in the electronic medical record, enabling them to act quickly when a patient's clinical status is rapidly changing," Arnsdorff said.

With the 10-minute cardiac troponin test cartridge, for example, emergency department staff can test, transmit and treat from the bedside. This helps healthcare providers maintain compliance with testing guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA), which call for a turnaround time of less than 60 minutes. By sharing these test results via a hospital's existing wireless network, caregivers have rapid access to information that can help determine if a patient is having a heart attack.

The device is certified for compatibility with existing wireless networks. It is also is compatible with point-of-care data management systems used with earlier versions of the i-Stat System.

For more information: www.abbottpointofcare.com

Related Content

ABSORB STEMI TROFI II trial, ESC 2015, bioresorbable vascular scaffold, BVS, STEMI patients

Image courtesy of Abbott Vascular

Feature | Stents Bioresorbable| September 04, 2015
A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal among patients...
FFR-CT, HeartFlow, PLATFORM trial, ESC 2015, ICA, fractional flow reserve, computed tomography

Image courtesy of HeartFlow Inc.

Feature | FFR Catheters| September 03, 2015
Results of the PLATFORM trial indicate fractional flow reserve computed tomography (FFR-CT) can obviate the need for...
Abbott i-STAT

The Abbott i-STAT System offers test results for the most commonly ordered tests in surgical and specialty care areas, including: blood gases, chemistries, lactate, electrolytes, hemoglobin and hematocrit, and coagulation (including PT/INR). 

Feature | Point of Care Testing| September 02, 2015 | Daniella Cramp
Hospital-based healthcare providers today are under greater pressure than ever to administer cost- and time-efficient
News | Structural Heart| September 02, 2015
An investigational material known as Bioabsorbable Cardiac Matrix (BCM), designed to prevent cardiac remodeling in...
acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study
Feature | Thrombectomy Devices| September 02, 2015
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery...
chest pain, triage, emergency department, new rapid assay, Dirk Westermann, BACC study, ESC 2015
News | Blood Testing| September 02, 2015
Emergency department patients with chest pain suggestive of acute myocardial infarction (AMI) can be triaged more...
Pie Medical Imaging, Frost & Sullivan, technology leadership, CAAS, cardiovascular diagnostics

CAAS MRV is part of Pie Medical Imaging's suite of imaging solutions for quantitative cardiovascular diagnosis and treatment planning. - See more at: http://www.itnonline.com/content/pie-medical-imaging-recognized-innovati...

News | Cardiac Imaging| September 01, 2015
Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical...
Absorb, BVS, bioresorbable stent
News | Stents Bioresorbable| September 01, 2015
September 1, 2015 — A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared t
bivalirudin,angiomax
Feature | Antiplatelet and Anticoagulation Therapies| September 01, 2015
September 1, 2015 — Extending treatment with the anticoagulant bivalirudin for at least four hours after completion o
Mitralign, Percutaneous Tricuspid Valve Annuloplasty System

Mitralign's Percutaneous Tricuspid Valve Annuloplasty System uses catheter delivered pledgeted sutures that can be cinched together to change the valve annulus geometry to help eliminate valvular regurgitation. 

News | Heart Valve Repair| August 31, 2015
August 31, 2015 — Mitralign Inc. said the U.S.
Overlay Init